Patents by Inventor Jiaxing YANG

Jiaxing YANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230146337
    Abstract: Provided in the present disclosure is a method for using a four-plasmid system to prepare modified immune effector cells. The method comprises: forming a lentivirus by using four plasmids within 293T cells, extracting and obtaining the lentivirus, then transfecting immune effector cells by using the lentivirus, and expressing a chimeric antigen receptor. Also provided in the present disclosure is a use of the immune effector cell obtained by using the described method and of a composition containing the immune effector cell.
    Type: Application
    Filed: October 5, 2022
    Publication date: May 11, 2023
    Applicant: JUVENTAS CELL THERAPY LTD.
    Inventors: Yun LIU, Lin SHI, Lulu LV, Pan XIE, Mengmeng CAO, Wang YANG, Jiaxing YANG, Fei WANG, Rui WANG
  • Patent number: 11497771
    Abstract: Provided in the present disclosure is a method for using a four-plasmid system to prepare modified immune effector cells. The method comprises: forming a lentivirus by using four plasmids within 293T cells, extracting and obtaining the lentivirus, then transfecting immune effector cells by using the lentivirus, and expressing a chimeric antigen receptor. Also provided in the present disclosure is a use of the immune effector cell obtained by using the described method and of a composition containing the immune effector cell.
    Type: Grant
    Filed: August 26, 2021
    Date of Patent: November 15, 2022
    Assignee: JUVENTAS CELL THERAPY LTD.
    Inventors: Yun Liu, Lin Shi, Lulu Lv, Pan Xie, Mengmeng Cao, Wang Yang, Jiaxing Yang, Fei Wang, Rui Wang
  • Publication number: 20220040233
    Abstract: Provided in the present disclosure is a method for using a four-plasmid system to prepare modified immune effector cells. The method comprises: forming a lentivirus by using four plasmids within 293T cells, extracting and obtaining the lentivirus, then transfecting immune effector cells by using the lentivirus, and expressing a chimeric antigen receptor. Also provided in the present disclosure is a use of the immune effector cell obtained by using the described method and of a composition containing the immune effector cell.
    Type: Application
    Filed: August 26, 2021
    Publication date: February 10, 2022
    Applicant: JUVENTAS CELL THERAPY LTD.
    Inventors: Yun LIU, Lin SHI, Lulu LV, Pan XIE, Mengmeng CAO, Wang YANG, Jiaxing YANG, Fei WANG, Rui WANG